Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Understanding aberrant RNA splicing to facilitate cancer diagnosis and therapy
Xuesen Dong, Ruiqi Chen
Oncogene (2019) Vol. 39, Iss. 11, pp. 2231-2242
Closed Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

The role of alternative splicing in cancer: From oncogenesis to drug resistance
Rocco Sciarrillo, Anna Wojtuszkiewicz, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100728-100728
Open Access | Times Cited: 197
SRSF9 mediates oncogenic RNA splicing of SLC37A4 via liquid–liquid phase separation to promote oral cancer progression
Peng Qiu, Lujuan Wang, Ying Long, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 1
Transcription Factors in Cancer: When Alternative Splicing Determines Opposite Cell Fates
Silvia Belluti, Giovanna Rigillo, Carol Imbriano
Cells (2020) Vol. 9, Iss. 3, pp. 760-760
Open Access | Times Cited: 60
Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics
Peng Qiu, Yujuan Zhou, Linda Oyang, et al.
Molecular Therapy (2021) Vol. 30, Iss. 3, pp. 1018-1035
Open Access | Times Cited: 55
Comprehensive characterisation of intronic mis-splicing mutations in human cancers
Hyunchul Jung, Kang Seon Lee, Jung Kyoon Choi
Oncogene (2021) Vol. 40, Iss. 7, pp. 1347-1361
Open Access | Times Cited: 44
Mechanisms of non-coding RNA-modulated alternative splicing in cancer
Xiaolin Wang, Jinghan Hua, Jingxin Li, et al.
RNA Biology (2022) Vol. 19, Iss. 1, pp. 541-547
Open Access | Times Cited: 30
RNA-Binding Proteins in Acute Leukemias
Konstantin Schuschel, Matthias Helwig, Stefan Hüttelmaier, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3409-3409
Open Access | Times Cited: 45
RBM10 Regulates Tumor Apoptosis, Proliferation, and Metastasis
Yingshu Cao, Xin Di, Qinghua Zhang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 33
RBM10 recruits METTL3 to induce N6-methyladenosine-MALAT1-dependent modification, inhibiting the invasion and migration of NSCLC
Yingshu Cao, Xin Di, Shan Cong, et al.
Life Sciences (2023) Vol. 315, pp. 121359-121359
Closed Access | Times Cited: 14
Pathogenic Mis-splicing of CPEB4 in Schizophrenia
Ivana Ollà, Antonio F. Pardiñas, Alberto Parras, et al.
Biological Psychiatry (2023) Vol. 94, Iss. 4, pp. 341-351
Open Access | Times Cited: 14
HnRNP-L-regulated circCSPP1/miR-520h/EGR1 axis modulates autophagy and promotes progression in prostate cancer
Jianming Lü, Chuanfan Zhong, Junqi Luo, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 26, pp. 927-944
Open Access | Times Cited: 32
Alternative Splicing, Epigenetic Modifications and Cancer: A Dangerous Triangle, or a Hopeful One?
Francisco Gimeno-Valiente, Gerardo López‐Rodas, Josefa Castillo, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 560-560
Open Access | Times Cited: 22
Design and synthesis of novel sulfur-substituted triptolide with the ability to induce autophagy through inhibition of SRSF1 expression
Xinyi Chen, Jichen Guan, Yuewei Lin, et al.
European Journal of Medicinal Chemistry (2025) Vol. 287, pp. 117342-117342
Closed Access
Intrinsic Regulatory Role of RNA Structural Arrangement in Alternative Splicing Control
Katarzyna Taylor, Krzysztof Sobczak
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 5161-5161
Open Access | Times Cited: 30
Identification of spliceosome components pivotal to breast cancer survival
Jing An, Zhehui Luo, Weiwei An, et al.
RNA Biology (2020) Vol. 18, Iss. 6, pp. 833-842
Open Access | Times Cited: 29
RNA-binding protein CELF1 enhances cell migration, invasion, and chemoresistance by targeting ETS2 in colorectal cancer
Huaiming Wang, Rongkang Huang, Wentai Guo, et al.
Clinical Science (2020) Vol. 134, Iss. 14, pp. 1973-1990
Closed Access | Times Cited: 28
Development of Proximity-Activated Programmable Multicomponent Nucleic Acid Enzymes for Simultaneous Visualization of Multiple mRNA Splicing Variants in Living Cells
Wenjing Liu, Han Yun, Rui Song, et al.
Analytical Chemistry (2025)
Closed Access
The Isoforms of Estrogen Receptor Alpha and Beta in Thyroid Cancer
Zhongqin Gong, Shucai Yang, Minghui Wei, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 15
Alternative mRNA Splicing and Promising Therapies in Cancer
James D. Fackenthal
Biomolecules (2023) Vol. 13, Iss. 3, pp. 561-561
Open Access | Times Cited: 8
SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A–c‐Myc axis
Jian‐Yu Yang, Yan‐Miao Huo, Minwei Yang, et al.
Molecular Oncology (2021) Vol. 15, Iss. 11, pp. 3076-3090
Open Access | Times Cited: 20
PRMT5: An Emerging Target for Pancreatic Adenocarcinoma
Michael K.C. Lee, Sean M. Grimmond, Grant A. McArthur, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5136-5136
Open Access | Times Cited: 18
Cisplatin-induced PANDAR-Chemo-EVs contribute to a more aggressive and chemoresistant ovarian cancer phenotype through the SRSF9-SIRT4/SIRT6 axis
Hao Wang, Yinuo Li, Yanan Wang, et al.
Journal of Gynecologic Oncology (2023) Vol. 35, Iss. 2
Open Access | Times Cited: 7
Characterization of alternative splicing events and prognostic signatures in gastric cancer
Nan Zhu, Yupeng Zhao, Wenjing Yan, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Alternative splicing and alternative polyadenylation define tumor immune microenvironment and pharmacogenomic landscape in clear cell renal carcinoma
Weimin Zhong, Yulong Wu, Maoshu Zhu, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 27, pp. 927-946
Open Access | Times Cited: 10
LMX1B Activated Circular RNA GFRA1 Modulates the Tumorigenic Properties and Immune Escape of Prostate Cancer
Min Meng, Yi-Chen Wu
Journal of Immunology Research (2022) Vol. 2022, pp. 1-23
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top